Using filters to reduce chemotherapy side effects
Endovascular Filtration to Change Drug Biodistribution (ELOCUTION)
This study is working on new devices that can help remove chemotherapy drugs from the bloodstream during treatment, making it safer and more effective for patients by reducing side effects while still targeting tumors.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11034975 on NIH RePORTER |
What this research studies
This research focuses on developing innovative catheter-based devices that can filter out chemotherapy drugs from the bloodstream during treatment. By using real-time x-ray imaging, these filters aim to minimize the systemic toxicity associated with chemotherapy while still allowing the drugs to target tumors effectively. The project will involve creating and testing prototypes of these filters in laboratory settings and animal models to ensure their safety and effectiveness. The ultimate goal is to improve the delivery of chemotherapy to specific organs while reducing harmful side effects.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients receiving intra-arterial chemotherapy for liver or brain tumors.
Not a fit: Patients who are not undergoing locoregional chemotherapy or those with conditions not related to the targeted organs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the side effects of chemotherapy for patients undergoing locoregional infusion therapy.
How similar studies have performed: Previous research has shown promise in using similar filtration techniques to reduce drug toxicity, indicating potential for success in this novel approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Hetts, Steven William — University of California, San Francisco
- Study coordinator: Hetts, Steven William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.